Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for ...
Download
1 / 5

Preclinical Models - PowerPoint PPT Presentation


  • 458 Views
  • Uploaded on
  • Presentation posted in: Industry

New Approaches for Conducting Preclinical Studies Improve the Quality of Preclinical Data and Speed up the Preclinical R&D Process

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha

Download Presentation

Preclinical Models

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies


New Approaches for Conducting Preclinical Studies Improve the Quality of Preclinical Data and Speed up the Preclinical R&D Process

Pharmaceutical/biotechnology companies partner with CROs, academic and government institutions to design and develop new approaches and models for conducting preclinical research. Advancements in molecular biology/genetic engineering and computational methods help researchers to tackle various problems in the preclinical research.

Simulation and system biology models improve the quality and reliability of preclinical data. Novel models by several pharmaceutical companies and contract research organizations proved to be effective in reducing preclinical process cycle time.

For further details, please click or add the below link to your browser:

http://www.gbiresearch.com/Report.aspx?ID=Preclinical-Models-Preclinical-CROs-will-Continue-to-Improve-the-Quality-and-Acccuracy-of-Data-for-Targeted-Therapies&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare


Contract Research Organizations Offer a Wide Range of Preclinical In-vitro and In-vivo Services to Enhance their Service Portfolio

Preclinical studies make use of systems or models such as in-vitro, in-vivo and in-silico models, for conducting a wide range of preclinical research and development studies. Absorption, distribution, metabolism, excretion and toxicology (ADMET) studies are conducted initially to investigate and correlate the test compound’s absorption, distribution, metabolism, excretion, and toxicology profile in preclinical systems with humans. There is considerable

number of contract research organizations (CROs), providing a wide range of preclinical design and testing services. Some of the top CROs such as Charles River Laboratories, Covance and Cyprotex offer both customized and standardized preclinical services and models to their clients (pharmaceutical and biotechnology companies) and they continue to grow with strategic acquisitions and partnerships. Furthermore CROs from Asian countries (especially from India and China) such as Jubilant Biosys, Advinus and Shanghai ChemPartner also emerging up with their customized preclinical offerings.

Preclinical Outsourcing Market is Expected to Grow with a Reasonable Growth Rate

GBI Research estimated that the global preclinical outsourcing market was


$3,779m in 2009 and it is expected to reach $7,919m in 2016, indicating a CAGR of 11.2%. Increasing R&D expenditure, qualitative and quantitative advantage in Asian countries with regard to preclinical R&D and requirements for laboratory animals drive the outsourcing market with positive growth trend. However flattened demand for outsourcing toxicology services and difficulty in acquiring experienced talent pool may hinder the preclinical outsourcing market growth.

GBI Research, the leading business intelligence provider, has released its latest report, “Preclinical Models- Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies” that provides key data, information and analysis of the major trends and developments in preclinical studies and preclinical outsourcing business. The report provides a comprehensive insight into key technological developments, new approaches in developing preclinical models. The report talks about the key outsourcing business models and factors that are driving the global preclinical outsourcing market. The report also provides a detailed analysis of global preclinical market in terms of preclinical spending and preclinical outsourced value. The report also provides key alliances and acquisitions related to preclinical studies among CROs.


This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

For further details, please click or add the below link to your browser:

http://www.gbiresearch.com/Report.aspx?ID=Preclinical-Models-Preclinical-CROs-will-Continue-to-Improve-the-Quality-and-Acccuracy-of-Data-for-Targeted-Therapies&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.gbiresearch.com

For more details contact:

pressreleases@gbiresearch.com

North America: +1 646 395 5477

Europe: +44 207 753 4299

+44 1204 543 533

Asia Pacific: +91 40 6616 6782


ad
  • Login